Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Liver fibrosis is the pathological process of excessive extracellular matrix deposition after liver injury and is a precursor to cirrhosis, hepatocellular carcinoma (HCC). It is essentially a wound healing response to liver tissue damage. Numerous studies have shown that hepatic stellate cells play...
Saved in:
Main Authors: | Fa-Da Wang (Author), Jing Zhou (Author), En-Qiang Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ovarian fibrosis: molecular mechanisms and potential therapeutic targets
by: Mengqing Gu, et al.
Published: (2024) -
Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
Published: (2020) -
Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
by: Cecilia Battistelli, et al.
Published: (2020) -
Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
by: Hongbo Ma, et al.
Published: (2022) -
Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
by: Erika Ramos-Tovar, et al.
Published: (2020)